CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $132,000 | +153.8% | 22,751 | +68.0% | 0.00% | – |
| Q2 2020 | $52,000 | +20.9% | 13,542 | +22.6% | 0.00% | – |
| Q1 2020 | $43,000 | +2.4% | 11,042 | +1.2% | 0.00% | – |
| Q4 2019 | $42,000 | -27.6% | 10,911 | -18.0% | 0.00% | – |
| Q3 2019 | $58,000 | +23.4% | 13,311 | +7.3% | 0.00% | – |
| Q3 2018 | $47,000 | +23.7% | 12,411 | 0.0% | 0.00% | – |
| Q2 2018 | $38,000 | +35.7% | 12,411 | +8.8% | 0.00% | – |
| Q1 2018 | $28,000 | -31.7% | 11,411 | +9.6% | 0.00% | – |
| Q4 2017 | $41,000 | – | 10,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |